Jump to content

Biotechnology patent applications on 11th September 2025

From WikiPatents
Revision as of 08:06, 11 September 2025 by Wikipatents (talk | contribs) (Technology trend analysis for Biotechnology patent applications on 11th September 2025)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Biotechnology Patent Applications on 11th September 2025

Executive Summary

On 11th September 2025, 183 patent applications related to Biotechnology were published, representing 2.6% of all patent applications for the day. This moderate level of activity shows Biotechnology is gaining significant attention from innovators.

Market Analysis

Leading Organizations

The top organizations driving Biotechnology innovation include:

Template:Newsletter signup box

These 5 organizations account for 16 applications (8.7% of all Biotechnology patents), indicating a diverse and competitive landscape.

Technology Deep Dive

Core Innovation Areas

Patent applications in Biotechnology encompass several key innovation areas:

Technical Classification Analysis

The most active CPC classifications in Biotechnology include:

  • C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 27 applications (14.8%)
  • C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 24 applications (13.1%)
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 19 applications (10.4%)
  • C12Q1/6886 (for cancer (immunoassay for cancer): 14 applications (7.7%)
  • C12N2750/14143 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 14 applications (7.7%)
  • C12Q1/6806 (Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (): 13 applications (7.1%)
  • C12Q1/6869 (Methods for sequencing): 13 applications (7.1%)
  • C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 12 applications (6.6%)
  • C12N9/226 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 11 applications (6.0%)
  • C12N2310/315 (of the backbone): 11 applications (6.0%)

Global Innovation Landscape

Innovation in Biotechnology spans multiple countries:

  • US: 433 inventors (53.4%)
  • KR: 74 inventors (9.1%)
  • CN: 48 inventors (5.9%)
  • JP: 44 inventors (5.4%)
  • GB: 39 inventors (4.8%)
  • DE: 25 inventors (3.1%)
  • CA: 18 inventors (2.2%)
  • FR: 18 inventors (2.2%)
  • RU: 15 inventors (1.8%)
  • BR: 14 inventors (1.7%)

The US accounts for 53.4% of inventors in Biotechnology, showing significant but not dominant innovation activity.

Industry Collaborations

Notable collaborations in Biotechnology include:

These collaborations represent 7 joint applications, indicating emerging collaboration trends in Biotechnology.

Leading Inventors

Key inventors driving Biotechnology innovation:

Recent Patent Applications

Representative Biotechnology patent applications from 11th September 2025:

20250280776. CORN ELITE EVENT MZIR260

Applicant: SYNGENTA CROP PROTECTION AG

Abstract: A novel transgenic corn elite event designated MZIR260 is disclosed. The invention relates to DNA sequences of the recombinant constructs inserted into the corn genome and of genomic sequences flanking the insertion site that resulted in elite event MZIR260. The invention further relates to assays for detecting the presence of the DNA sequences of corn elite event MZIR260, to corn plants and corn seeds comprising the genotype thereof, and to methods for producing a corn plant by crossing a corn ...

20250280777. METHODS FOR SELECTING WATERMELON PLANTS AND PLANT PARTS COMPRISING A MODIFIED DWARF14 GENE

Applicant: NUNHEMS BV

Abstract: The present invention is directed to a genotyping method for a gene named DWARF 14 in watermelon, cucumber or melon, which, when mutated, confers an increased secondary branching phenotype. Also plants comprising modifications in the DWARF 14 gene are provided herein.

20250280778. 'SAMKWANG(SA)-FLO3', RICE MUTANT LINE DERIVED FROM 'SAMKWANG' WITH FLOURY ENDOSPERM

Applicant: Republic Of Korea (Management Rural Development Administration)

Abstract: The present invention relates to novel ‘Samkwang (SA)-flo3’, a mutant line derived from ‘Samkwang’ with floury endosperm, and a use thereof. More specifically, the present invention includes ‘Samkwang (SA)-flo3’ with floury endosperm suitable for exclusive production of dry-milled rice flour and relates to a method for breeding the rice cultivar, a composition, a kit, a method for determining floury endosperm characteristics of rice in the next generation of the rice cultivar, and a food composi...

20250280779. CORN ELITE EVENT MZIR260

Applicant: Syngneta Crop Protection Ag

Abstract: A novel transgenic corn elite event designated MZIR260 is disclosed. The invention relates to DNA sequences of the recombinant constructs inserted into the corn genome and of genomic sequences flanking the insertion site that resulted in elite event MZIR260. The invention further relates to assays for detecting the presence of the DNA sequences of corn elite event MZIR260, to corn plants and corn seeds comprising the genotype thereof, and to methods for producing a corn plant by crossing a corn ...

20250280803. ARTIFICIAL RECOMBINANT CHROMOSOME AND USE THEREOF

Applicant: Humab Co Ltd

Abstract: The disclosure in the specification relates to an artificial recombinant chromosome and the use thereof, and more particularly to an artificial recombinant chromosome generated by the recombination of two or more chromosomes and a production of a transgenic animal using a cell including the same. Especially, in the disclosure in the specification, an interchromosomal exchange between the recipient chromosome and the donor chromosome has many merits to produce the artificial recombinant chromosom...

Market Implications

Innovation Intensity

With 183 applications in a single day, Biotechnology demonstrates very high innovation intensity, suggesting rapid technological advancement and strong commercial interest.

Competitive Landscape

Innovation in Biotechnology involves 200 organizations, indicating a highly competitive and diverse landscape with many players investing in R&D.

Technology Outlook

Emerging themes in Biotechnology patents include: methods, comprising, nucleic, acid, with, suggesting future development in these areas.

The current patent activity level suggests Biotechnology is in a growth phase with increasing market adoption and investment.

Related Technology Areas

Innovation in Biotechnology often intersects with other emerging technologies:

Analysis Tools

Search Resources

See Also

Retrieved from "https://wikipatents.org/index.php?title=Biotechnology_patent_applications_on_11th_September_2025&oldid=671271"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.